Summary
The global IBS-C Drugs market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx, Inc
Synthetic Biologics, Inc
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring BV
Ironwood Pharmaceuticals, Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca Plc
The Menarini Group
Ono Pharmaceutical Co., Ltd
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure IBS-C Drugs Picture
1.1.2 Specifications
Table Product Specifications of IBS-C Drugs
1.2 Market Segment
1.2.1 by Type
Table Products Segment of IBS-C Drugs
Table Global IBS-C Drugs Market by Type, 2016-2026 (USD Million)
1.2.1.1 Linaclotide
Table Linaclotide Overview
1.2.1.2 Lubiprostone
Table Lubiprostone Overview
1.2.1.3 Osmotic Laxatives
Table Osmotic Laxatives Overview
1.2.1.4 Stimulant Laxatives
Table Stimulant Laxatives Overview
1.2.1.5 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of IBS-C Drugs
Table Global IBS-C Drugs Market by Application, 2016-2026 (USD Million)
1.2.2.1 Hospital Pharmacies
Table Hospital Pharmacies Overview
1.2.2.2 Retail Pharmacies
Table Retail Pharmacies Overview
1.2.2.3 Online Pharmacies
Table Online Pharmacies Overview
1.2.3 by Regions
Table Global IBS-C Drugs Market by Region, 2016-2026 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of IBS-C Drugs
2.2 Upstream
Table Cost of IBS-C Drugs
Figure Manufacturing Process of IBS-C Drugs
2.3 Market
2.3.1 SWOT
Figure SWOT of IBS-C Drugs
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of IBS-C Drugs
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of IBS-C Drugs
3.4 Market Entry
Table Market Entry of IBS-C Drugs
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Linaclotide Market, 2016-2020
Figure Linaclotide Market Size and Growth, 2016-2020 (USD Million)
Figure Linaclotide Market Size and Growth, 2016-2020 (in Volume)
Table Linaclotide CAGR by Revenue and Volume, 2016-2020
4.1.2 Lubiprostone Market, 2016-2020
Figure Lubiprostone Market Size and Growth, 2016-2020 (USD Million)
Figure Lubiprostone Market Size and Growth, 2016-2020 (in Volume)
Table Lubiprostone CAGR by Revenue and Volume, 2016-2020
4.1.3 Osmotic Laxatives Market, 2016-2020
Figure Osmotic Laxatives Market Size and Growth, 2016-2020 (USD Million)
Figure Osmotic Laxatives Market Size and Growth, 2016-2020 (in Volume)
Table Osmotic Laxatives CAGR by Revenue and Volume, 2016-2020
4.1.4 Stimulant Laxatives Market, 2016-2020
Figure Stimulant Laxatives Market Size and Growth, 2016-2020 (USD Million)
Figure Stimulant Laxatives Market Size and Growth, 2016-2020 (in Volume)
Table Stimulant Laxatives CAGR by Revenue and Volume, 2016-2020
4.1.5 Others Market, 2016-2020
Figure Others Market Size and Growth, 2016-2020 (USD Million)
Figure Others Market Size and Growth, 2016-2020 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2020
4.2 Market Forecast
4.2.1 Linaclotide Market Forecast, 2021-2026
Figure Linaclotide Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Linaclotide Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Linaclotide CAGR by Revenue and Volume, 2016-2026
4.2.2 Lubiprostone Market Forecast, 2021-2026
Figure Lubiprostone Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Lubiprostone Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Lubiprostone CAGR by Revenue and Volume, 2016-2026
4.2.3 Osmotic Laxatives Market Forecast, 2021-2026
Figure Osmotic Laxatives Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Osmotic Laxatives Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Osmotic Laxatives CAGR by Revenue and Volume, 2016-2026
4.2.4 Stimulant Laxatives Market Forecast, 2021-2026
Figure Stimulant Laxatives Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Stimulant Laxatives Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Stimulant Laxatives CAGR by Revenue and Volume, 2016-2026
4.2.5 Others Market Forecast, 2021-2026
Figure Others Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Others Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Others CAGR by Revenue and Volume, 2016-2026
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Pharmacies Market, 2016-2020
Figure Hospital Pharmacies Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Hospital Pharmacies CAGR by Revenue and Volume, 2016-2020
5.1.2 Retail Pharmacies Market, 2016-2020
Figure Retail Pharmacies Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Retail Pharmacies CAGR by Revenue and Volume, 2016-2020
5.1.3 Online Pharmacies Market, 2016-2020
Figure Online Pharmacies Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Online Pharmacies CAGR by Revenue and Volume, 2016-2020
5.2 Market Forecast
5.2.1 Hospital Pharmacies Market Forecast, 2021-2026
Figure Hospital Pharmacies Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Hospital Pharmacies Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Hospital Pharmacies CAGR by Revenue and Volume, 2021-2026
5.2.2 Retail Pharmacies Market Forecast, 2021-2026
Figure Retail Pharmacies Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Retail Pharmacies Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Retail Pharmacies CAGR by Revenue and Volume, 2021-2026
5.2.3 Online Pharmacies Market Forecast, 2021-2026
Figure Online Pharmacies Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Online Pharmacies Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Online Pharmacies CAGR by Revenue and Volume, 2021-2026
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2016-2020
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2016-2020
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Table North America CAGR by Revenue and Volume, 2016-2020
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2016-2020
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Table Europe CAGR by Revenue and Volume, 2016-2020
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2016-2020
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Table South America CAGR by Revenue and Volume, 2016-2020
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2016-2020
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2021-2026
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
6.2.2 North America Market Forecast, 2021-2026
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table North America CAGR by Revenue and Volume, 2021-2026
6.2.3 Europe Market Forecast, 2021-2026
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Europe CAGR by Revenue and Volume, 2021-2026
6.2.4 South America Market Forecast, 2021-2026
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table South America CAGR by Revenue and Volume, 2021-2026
6.2.5 Middle East & Africa Market Forecast, 2021-2026
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026
7 Market Competitive
7.1 Global Market by Vendors
Table Global IBS-C Drugs Market by Vendors, 2016-2020 (in Volume)
Table Global IBS-C Drugs Market Share by Vendors, 2016-2020 (USD Million)
Table Global IBS-C Drugs Market Share by Vendors, 2016-2020 (in Volume)
7.2 Market Concentration
Figure IBS-C Drugs Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Catalent Pharmaceuticals Solutions
Table Catalent Pharmaceuticals Solutions Profile List
Table Microecological Modulator Operating Data of Catalent Pharmaceuticals Solutions (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Nestle
Table Nestle Profile List
Table Microecological Modulator Operating Data of Nestle (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Abbott Laboratories
Table Abbott Laboratories Profile List
Table Microecological Modulator Operating Data of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Synergy Pharmaceuticals
Table Synergy Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Synergy Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Sucampo Pharmaceuticals
Table Sucampo Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Sucampo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Novartis Pharma Ag
Table Novartis Pharma Ag Profile List
Table Microecological Modulator Operating Data of Novartis Pharma Ag (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Astellas Pharmaceuticals
Table Astellas Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Astellas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Ardelyx, Inc
Table Ardelyx, Inc Profile List
Table Microecological Modulator Operating Data of Ardelyx, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Synthetic Biologics, Inc
Table Synthetic Biologics, Inc Profile List
Table Microecological Modulator Operating Data of Synthetic Biologics, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Teva Pharmaceutical Industries
Table Teva Pharmaceutical Industries Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Bama-Geve, SLU
Table Bama-Geve, SLU Profile List
Table Microecological Modulator Operating Data of Bama-Geve, SLU (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Ferring BV
Table Ferring BV Profile List
Table Microecological Modulator Operating Data of Ferring BV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Ironwood Pharmaceuticals, Inc
Table Ironwood Pharmaceuticals, Inc Profile List
Table Microecological Modulator Operating Data of Ironwood Pharmaceuticals, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Salix Pharmaceuticals Ltd
Table Salix Pharmaceuticals Ltd Profile List
Table Microecological Modulator Operating Data of Salix Pharmaceuticals Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 Norgine B.V
Table Norgine B.V Profile List
Table Microecological Modulator Operating Data of Norgine B.V (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 Prometheus Laboratories Inc
Table Prometheus Laboratories Inc Profile List
Table Microecological Modulator Operating Data of Prometheus Laboratories Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.17 Actavis Nordic A/S
Table Actavis Nordic A/S Profile List
Table Microecological Modulator Operating Data of Actavis Nordic A/S (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.18 Albireo Pharma Inc
Table Albireo Pharma Inc Profile List
Table Microecological Modulator Operating Data of Albireo Pharma Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.19 Yuhan Corp
Table Yuhan Corp Profile List
Table Microecological Modulator Operating Data of Yuhan Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.20 Astrazeneca Plc
Table Astrazeneca Plc Profile List
Table Microecological Modulator Operating Data of Astrazeneca Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.21 The Menarini Group
Table The Menarini Group Profile List
Table Microecological Modulator Operating Data of The Menarini Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.22 Ono Pharmaceutical Co., Ltd
Table Ono Pharmaceutical Co., Ltd Profile List
Table Microecological Modulator Operating Data of Ono Pharmaceutical Co., Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
The Antimetabolite Drugs Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/...
The GLP-1 Peptide Drugs Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/p...
Executive Summary
Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...
Executive Summary
Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoro...
Overview of the Global Sex Hormone Drugs Market:
The report discusses everything a marketer requires before investing in the global Sex Hormone Drugs Market during the forecast period 2023-2030. It provides detailed...
Executive Summary
Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...
Overview of the Global Microecological Drugs Market :
The report discusses everything a marketer requires before investing in the global Microecological Drugs Market during the forecast period 2023-2030. It provide...
Overview of the Global Biosynthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Biosynthesis Peptide Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Chemical Synthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Chemical Synthesis Peptide Drugs Market during the forecast period 2...
Description
The global veterinary dermatology drugs market exhibits positive growth prospects, forecast to expand at a CAGR of 5.4% between 2023 and 2029 to reach USD 8.08 billion in value. Veterinary dermatology focuses on treating skin diseases and disorders in animal patients, covering both...